Novavax: fresh buy signal, up 11.1%
Novavax surges 11.1% and triggers a fresh Buy signal
Our view last week
After last week's 8.6% bounce, Novavax is slowing down: the stock gains just 1.3% this week, with buyers slipping from 84% to 66% of volume. Money flow stays negative but keeps improving, and the weekly ADX keeps sliding — the decline is losing conviction without reversing. Having bounced off its own 20-day average, price is now pressing against the 7-day high: the short remains in profit, above 9%.
This week's summary
Novavax bounces 9% off its own 20-day moving average and closes the week up 11.1%: a fresh buy signal has just switched on for Novavax stock, 5th among the 14 new Long setups for US stocks in our ranking. The healthcare sector is pulling its weight, with the reference ETF up more than 4% this week, and the price is now pressing against its 7-day high — the level it still has to clear to trigger full entry. Warning signs remain: money flow is still negative, even if it's improving.
IQS Phase
49
ordinary
Signal Strength
76
high · wide & volatile
Sizing
FULL
Ranking
#5 / 14
New us stocks
Trade P&L %
+0.00%
from signal to date, no stop loss
Rank position
ranks 5th among the 14 fresh Longs for US stocks in our ranking, with a signal strength of 76 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
NVAX belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content